Amanta Healthcare IPO Leads Week of Seven New Offerings in Indian Primary Market

2 min read     Updated on 31 Aug 2025, 08:10 AM
scanx
Reviewed by
Riya DeyScanX News Team
whatsapptwittershare
Overview

The Indian primary market is set for a busy week with seven new IPOs launching, including one mainboard IPO and six SME offerings. Amanta Healthcare Ltd. leads with a mainboard IPO aiming to raise Rs 126.00 crore, priced at Rs 120.00-126.00 per share. The funds will be used for capital expenditure and equipment purchase. Six SME companies, including Sharvaya Metals Ltd., Rachit Prints Ltd., and Optivalue Tek Consulting Ltd., are also launching IPOs. Two companies are scheduled for listing, and six SME companies will debut next week. The IPO pipeline remains strong with 69 companies under SEBI review. Notably, Groww, a fintech platform, has received approval for a potential $1.00 billion IPO.

18153648

*this image is generated using AI for illustrative purposes only.

The Indian primary market is gearing up for a busy week with seven new Initial Public Offerings (IPOs) set to launch, including one mainboard IPO and six from the Small and Medium Enterprise (SME) segment.

Amanta Healthcare's Mainboard IPO

Amanta Healthcare Ltd., a manufacturer of medical devices and sterile liquid products, is leading the pack with its mainboard IPO. The company aims to raise Rs 126.00 crore through a book-built issue of 1 crore fresh shares. The price band for the offering has been set at Rs 120.00-126.00 per share.

The proceeds from the IPO are earmarked for specific purposes:

  • Capital expenditure
  • Equipment purchase for a new manufacturing line in Gujarat

SME Segment Offerings

Alongside Amanta Healthcare, six SME companies are also launching their IPOs this week. Notable among these are:

  • Sharvaya Metals Ltd.
  • Rachit Prints Ltd.
  • Optivalue Tek Consulting Ltd.

Upcoming Listings and Debuts

The market is also anticipating new listings:

  • Two companies, Anlon Healthcare Ltd. and Vikran Engineering Ltd., are scheduled to list their shares.
  • Six SME companies are set to make their market debut next week.

IPO Pipeline

The IPO pipeline remains robust with several companies at various stages of the approval process:

  • Ardee Engineering Ltd. has received SEBI approval for a mixed offering worth Rs 580.00 crore.
  • Groww, a prominent fintech platform, has had its confidential IPO filing approved. The offering is potentially valued at $1.00 billion, signaling significant investor interest in the fintech sector.

Market Overview

The current IPO landscape in India shows continued momentum:

  • 69 companies currently have IPO applications under review by the Securities and Exchange Board of India (SEBI).

This week's offerings, particularly the Amanta Healthcare IPO, reflect the ongoing interest in the healthcare and medical devices sector. The diverse range of SME offerings also highlights the growing participation of smaller companies in the public markets.

Investors and market watchers will be keenly observing these IPOs, especially given the mix of sectors represented and the varying scales of the offerings. As always, potential investors are advised to carefully review the offer documents and consider their risk appetite before participating in any IPO.

The success of these IPOs could provide insights into investor sentiment and sector-specific trends in the Indian market. With Groww's potential billion-dollar IPO on the horizon, the fintech sector, in particular, may see increased attention in the coming months.

As the Indian primary market continues to evolve, the balance between mainboard and SME offerings demonstrates the market's capacity to cater to companies of different sizes and stages of growth, potentially contributing to a more diverse and dynamic economic landscape.

like17
dislike

Amanta Healthcare IPO Set to Open with Promising Grey Market Premium

1 min read     Updated on 29 Aug 2025, 10:39 AM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

Amanta Healthcare Ltd., a specialized pharmaceutical company, is launching its IPO on September 1. The mainboard issue aims to raise Rs 126 crore by offering one crore fresh shares priced between Rs 120-126. The grey market shows a premium of Rs 22 per share, indicating potential listing gains of 17.46%. The company specializes in sterile liquid pharmaceuticals and has seen a significant increase in net profit from Rs 3.63 crore to Rs 10.50 crore, despite a slight decrease in total income. IPO proceeds will fund new manufacturing lines at the Hariyala facility. The IPO closes on September 3, with listing expected on September 9 on BSE and NSE.

17989762

*this image is generated using AI for illustrative purposes only.

Amanta Healthcare Ltd., a specialized pharmaceutical company, is gearing up for its Initial Public Offering (IPO) set to launch on September 1. The mainboard issue, priced in the range of Rs 120-126 per share, aims to raise Rs 126.00 crore through the issuance of one crore fresh shares.

Grey Market Indicates Potential Listing Gains

The grey market is showing a positive sentiment towards Amanta Healthcare's IPO, with a premium of Rs 22.00 per share. This suggests an estimated listing price of Rs 148.00, potentially offering gains of 17.46% to investors upon listing.

Company Profile and Performance

Amanta Healthcare specializes in developing sterile liquid pharmaceutical products using advanced technologies. The company's product portfolio includes over 45 generic products, which are distributed through a network of 320 distributors. Additionally, the company has established its presence in international markets through exports to multiple regions.

Financial Highlights

While the company's total income saw a slight decrease from Rs 281.61 crore to Rs 276.09 crore, its profitability showed significant improvement:

Financial Metric Previous Period Recent Period
Total Income Rs 281.61 crore Rs 276.09 crore
Net Profit Rs 3.63 crore Rs 10.50 crore

The substantial increase in net profit, despite a marginal decrease in total income, indicates improved operational efficiency and cost management.

IPO Proceeds Utilization

The funds raised through the IPO will be primarily used to finance new manufacturing lines at the company's Hariyala facility. This expansion is likely aimed at enhancing production capabilities and potentially broadening the product range.

Key Dates for Investors

  • IPO Opening Date: September 1, 2023
  • IPO Closing Date: September 3, 2023
  • Expected Listing Date: September 9, 2023
  • Listing Venues: BSE and NSE

Investors interested in participating in the Amanta Healthcare IPO should note these dates and conduct thorough research before making any investment decisions. As always, it's advisable to review the company's prospectus and consult with financial advisors to assess the suitability of this investment opportunity in line with individual financial goals and risk tolerance.

like15
dislike
Explore Other Articles